Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

SABCS 2022 | Future directions for the Genetics and Inflammatory Markers for CIPN Study (GENIE) study

Daniel Rotroff, PhD, Lerner Research Institute, Cleveland, OH, discusses the next steps for the Genetics and Inflammatory Markers for CIPN Study (GENIE) study, including conducting an additional Phase of the stud to validate the accuracy of the model. This interview took place at the San Antonio Breast Cancer Symposium (SABCS) 2022 in San Antonio, TX.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.